Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Select Therapeutics signs agreement for cancer vaccine platform technology

June 24, 1998

Lilly presents results of first clinical trial evaluating the MDR modulator LY-335979

June 23, 1998

Czech investigators describe novel CDK inhibitor with potent antitumor activity

June 23, 1998

SB-RA-131012, an MDR-reversing taxane

June 23, 1998

Enzon allowed patent on its PEG technology

June 23, 1998

ZD-1839, an EGFR-TK inhibitor worthy of further testing

June 23, 1998

Aphton and SmithKline Beecham form alliance for Gonadimmune

June 22, 1998

SB-T-101131, a second-generation taxane with improved efficacy in MDR tumors

June 22, 1998

Immunex awarded gene patent on TRAIL molecule

June 22, 1998

L-NDDP, a liposomal cisplatin derivative in phase II testing

June 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.